Our study provides a nomogram model based on CEA and CYFRA21‐1 as a convenient tool for individualized prediction of the concordance of plasma and tumor biopsies, to optimize the utility of plasma biopsy in genotyping for advanced lung adenocarcinoma patients. This evidence concerns the gene CEACAM5 and neoplasm.